Mu opioid receptors in pain management
Authors:
- Gavril PasternakGPGavril Pasternak
- Ying-Xian PanYPYing-Xian Pan
- 1 March 2011
- journal article
- review article
- Published by Elsevier in Acta Anaesthesiologica Taiwanica
- Vol. 49 (1) , 21-25
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Drug Abuse (DA02615, DA07242, DA06241 and DA00220, DA013997 and DA029244)
This publication has 67 references indexed in Scilit:
- Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actionsProceedings of the National Academy of Sciences, 2009
- Isolation and characterization of new exon 11‐associated N‐terminal splice variants of the human mu opioid receptor geneJournal of Neurochemistry, 2009
- Novel receptor mechanisms for heroin and morphine-6β-glucuronide analgesiaNeuroscience Letters, 1996
- Antisense mapping the MOR‐1 opioid receptor: evidence for alternative splicing and a novel morphine‐6β‐glucuronide receptorFEBS Letters, 1995
- Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ, δ or κ opioid receptor typeFEBS Letters, 1994
- Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene familyFEBS Letters, 1994
- Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptorLife Sciences, 1994
- Specific μ2 opioid isoreceptor regulation of nigrostriatal neurons: in vivo evidence with naloxonazineNeuroscience Letters, 1983
- Naloxonazine, a potent, long-lasting inhibitor of opiate binding sitesLife Sciences, 1982
- A pituitary endorphin with novel propertiesLife Sciences, 1979